SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing sharp downward pressure as community members react to unfavorable legal rulings concerning platform safety and addictive design, sparking heated debates over whether this creates a buying opportunity or signals long-term regulatory risk. While some investors view the sell-off as an overreaction to manageable legal costs, others are bracing for further volatility amid broader market concerns over AI spending, potential war, and the precedent these cases set for the entire social media sector.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market participants are actively debating the legitimacy of recent after-hours announcements regarding a pause in geopolitical tensions, with many community members labeling the recurring price swings as deliberate market manipulation by political leadership. The consensus among traders reflects deep frustration with extreme volatility and the perceived disconnect between policy rhetoric and actual market outcomes, leading to a climate of heightened skepticism toward short-term news-driven rallies.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The market is experiencing significant volatility and downward pressure as investors grow increasingly skeptical of Trump's diplomatic claims regarding the Iran conflict, with many in the community labeling his statements as market manipulation. Traders are actively debating whether to buy the dip or prepare for a deeper bear market, as sentiment shifts toward the belief that tweets no longer carry their previous weight in steering market direction.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is facing intense volatility as market participants react to escalating geopolitical tensions and erratic messaging surrounding potential military actions in the Middle East. The community is actively debating the stock's stability amidst heavy skepticism regarding official communications, with many users focusing on the broader impact of administration policies on both their portfolios and the global economy.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing intense volatility and bearish sentiment as investors weigh the competitive threat of new AI models against the company's efforts to grow its advertising segment and streamline operations. Community discussion is heavily divided between those viewing the stock as a deeply undervalued long-term opportunity and others concerned that AI could fundamentally disrupt the company's traditional game engine model.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is capturing significant community attention as a community-driven, permissionless brand that focuses on long-term growth through tangible, real-world initiatives. Supporters are rallying around the project's consistent, daily efforts to build products and services, emphasizing a collective 'Kendu' attitude as the key to sustained success.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as shares surged following positive topline Phase 3 results for its drug Zenkuda, which successfully met primary and secondary endpoints in treating diabetic retinopathy. The community is actively discussing the stock's significant price volatility, debating the potential for a short squeeze given the high short interest, and weighing the company's long-term prospects as it moves from clinical trials toward a potential BLA submission.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is currently experiencing intense volatility as traders debate whether the index is facing a deeper correction or a potential bounce point, heavily influenced by shifting headlines regarding Middle East tensions. Community sentiment is deeply polarized, with active discussions focused on whether recent price movements are being driven by genuine geopolitical risk or orchestrated manipulation following conflicting political narratives.

Greenland Energy Co.

Greenland Energy Company, formerly trading as Pelican Acquisition Corporation, is capturing significant community attention surrounding its business combination and exploration efforts in the Jameson Land Basin. Investors are actively debating the company's long-term potential as an energy producer in the region while speculating on future price momentum and the impact of the upcoming ticker transition to GLND.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is trending following speculative buyout rumors linked to Eli Lilly and significant volume spikes that have ignited community debate over potential valuation and long-term M&A prospects. Investors are closely monitoring its market leadership in the MASH space as the company navigates competition and expands its pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kyverna Therapeutics (NASDAQ:KYTX) Announces Earnings Results

Kyverna Therapeutics (NASDAQ:KYTX - Get Free Report) posted its earnings results on Thursday. The company reported ($0.80) earnings per share (EPS) for the quarter, meeting the consensus estimate of...

Kyverna Therapeutics (KYTX) Expected to Announce Quarterly Earnings on Wednesday

Kyverna Therapeutics (NASDAQ:KYTX) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at...

Kyverna Therapeutics (NASDAQ:KYTX) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded Kyverna Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...

Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...

Wall Street Zen Downgrades Kyverna Therapeutics (NASDAQ:KYTX) to Sell

Wall Street Zen lowered Kyverna Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Given Average Rating of "Moderate Buy" by Analysts

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the five analysts that are covering the stock, Marketbeat.com reports...

Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research report on Sunday...

Kyverna Therapeutics (NASDAQ:KYTX) Rating Lowered to "Sell" at Wall Street Zen

Wall Street Zen cut Kyverna Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Given Consensus Rating of "Moderate Buy" by Analysts

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the company...

Kyverna Therapeutics Stock Up 41% in a Month: Here's Why

KYTX's shares surge after positive phase II data showed its CAR T miv-cel delivered major mobility gains in stiff person syndrome.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

KYTX
Kyverna Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KYTX News

KYTXKyverna Therapeutics Inc.